Back to news archive
News 2019-08-21

Gradientech Announces Notice of Allowance from USPTO

Gradientech today announces that it has received a Notice of Allowance from the United States Patent and Trademark Office (USPTO) for patent application no. 14/903,032, “Use of Fluidic Device”. The patent application covers the proprietary minimum inhibitory concentration (MIC) determination of a bacterial sample within a microfluidic controlled environment that is part of the technology platform of the Company’s diagnostic system QuickMIC™ for ultra-rapid AST in development.

Link to press-release

Gradientech is an ISO13485 certified company since 2017

Contact

Gradientech AB
Uppsala Science Park
SE-751 83 Uppsala
Sweden

sales@gradientech.se

About Gradientech

Gradientech develops, manufactures and sells innovative microfluidic products for high-quality analysis of the behavior of cells and organisms in response to gradients of biomolecules. Our aim is to pioneer life science and healthcare.

Copyright © 2024 Gradientech. All rights reserved. Gradientech, QuickMIC and CellDirector are registered trademarks or trademarks of Gradientech AB.

Next-generation antimicrobial susceptibility testing

Take a look at our E-book